Now in its 6th year, BioMelbourne Network’s annual Devices + Diagnostics Lab is renowned for providing attendees with the practical knowledge and actionable insights necessary for the development and commercialisation of medical technologies.
The full day, interactive program features local and international speakers across business, industry, academia and healthcare to highlight emerging industry trends, case studies of transformational healthcare solutions, and strategies for launching successful products in the global healthcare market.
The theme for the event this year is “disruptive diagnostics,” and will explore the changing landscape for medical diagnostics and devices – how new technologies are disrupting traditional models of business, the role of big data and data analytics, the value of these technologies for patients and which unmet clinical needs remain.
Speakers will explore the opportunities, challenges and complexities around: defining value proposition; understanding unmet clinical need; strategies for determining a pathway to market; navigating partnership agreements; capital raising and deal structuring.
The program includes keynote speakers, panel discussions, case studies, interactive Q&A sessions and plenty of time for networking. This event is also timed to coincide with the Victorian State Government’s 2018 Victoria Invitation Program – which showcases Victoria to business leaders from around the world – creating the opportunity for international delegates to attend sessions and engage with local sector leaders.
Kelly Krajnik, Business Development Manager, Mayo Clinic Ventures (USA)
Rick Legleiter, CEO, Universal Biosensors
Dr Sacha Dopheide, CEO, Lumos Diagnostics
Stephen Tomisich, Chairman & Founder, Trajan Scientific and Medical
Associate Professor Clara Gaff, Executive Director, Melbourne Genomics Health Alliance
Serina Cucuzza, Executive General Manager, Commercial Strategy, Burnet Institute
Dr Nic Woods, Health Industry Executive, Microsoft Australia
Dr Andre Tan, Business Development Manager, Australia & New Zealand, HistoIndex Pte Ltd (Singapore)
Dr Jason Ross, Senior Research Scientist, CSIRO Health & Biosecurity
Bronwyn Le Grice, CEO & Managing Director, ANDHealth
Associate Professor Marion Saville, Executive Director, Victorian Cytology Service
Frank Jaskulke, VP Intelligence, Medical Alley Association (USA)
Dr Kerry Hegarty, Advisor, Director, Victorian Government – Science, Medical Research and Technology, Ministerial Advisory Panel
Professor Anton van den Hengel, Director, Australian Institute for Machine Learning
Dr Michaella Richards, Director Business Development, Global Kinetics Corporation
View the program here
When: Tuesday 27th March 2018
Schedule: Registration and pre-event networking from 8.15am.
Official event opening by the Hon. Phillip Dalidakis at 8.45am
Program sessions 9.00am – 5.30pm, followed by networking drinks until 6.30pm.
Where: Lecture Theatre B, Level 7, Peter MacCallum Cancer Centre @ VCCC, 305 Grattan Street, Melbourne
(Prices include GST)
To check if your organisation is a member click here
A full refund is given up to 7 days prior to the event
No refunds within 7 days of the event